Role of Thymus on Prognosis of Myasthenia Gravis in Turkish Population
Open Access
- 1 January 2020
- journal article
- research article
- Published by Kare Publishing in Northern Clinics of Istanbul
- Vol. 7 (5), 452-459
- https://doi.org/10.14744/nci.2020.51333
Abstract
OBJECTIVE: Myasthenia gravis (MG) is an autoimmune disease that may cause a disorder in transmission at the neuromuscular junction. Antibodies directed against acetylcholine receptors are responsible. The thymus is the place that that production of these antibodies mainly occurs. The thymus gland abnormalities and abnormal production of these antibodies are associated with MG. Consequently, thymectomy is a common treatment for MG. The nature of the disease makes it difficult to plan prospective, controlled trials; therefore, there is no current consensus among clinicians on a single algorithm of treatment, and the approach is frequently based on the observations and experiences of experts. The contributions to the literature largely consist of retrospective studies examining an approach to treatment and the effects of thymectomy on prognosis. In this retrospective study, evaluation of Turkish patients with myasthenia gravis was carried out for the importance of thymectomy and effects on prognosis. METHODS: In this study, 93 patients with myasthenia gravis whose followed up at Neuromuscular outpatient clinic between 1998-2018 were evaluated retrospectively. Type of disease, antibody status, treatment, thymectomy, thymus pathology and prognosis were assessed. RESULTS: Thymectomy had been a positive effect on the prognosis of the disease independent of the duration of disease and thymic pathology. The best results had been obtained with early thymectomy with short disease duration, younger age and patients with thymic hyperplasia. Success of therapy was limited with thymoma. With advanced age need for thymectomy was decreased. CONCLUSION: In the present study, evaluation of 93 patients with myasthenia gravis was done retrospectively and it was concluded that thymectomy had a positive effect on prognosis, especially in young patients when performed as early as possible. The most successful results were obtained in cases with thymic hyperplasia.Keywords
This publication has 22 references indexed in Scilit:
- Myasthenia gravis as a prognostic marker in patients with thymomaJournal of Thoracic Disease, 2018
- Comparative clinical outcomes after thymectomy for myasthenia gravis: Thoracoscopic versus trans-sternal approachAsian Journal of Surgery, 2018
- Myasthenia GravisThe New England Journal of Medicine, 2016
- Myasthenia gravis — autoantibody characteristics and their implications for therapyNature Reviews Neurology, 2016
- Thymic carcinoma patients with myasthenia gravis exhibit better prognosesInternational Journal of Clinical Oncology, 2015
- MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4Proceedings of the National Academy of Sciences of the United States of America, 2013
- Antibodies against low-density lipoprotein receptor–related protein 4 induce myasthenia gravisJCI Insight, 2013
- Bilateral video-assisted thoracoscopic thymectomy has a surgical extent similar to that of transsternal extended thymectomy with more favorable early surgical outcomes for myasthenia gravis patientsSurgical Endoscopy, 2010
- Myasthenia gravisNeurology, 2000
- Repeat thymectomy in chronic refractory myasthenia gravisNeurology, 1991